Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study

Background: To verify whether, in patients on metformin (MET) monotherapy for type 2 diabetes (T2D), the add-on of a dipeptidyl peptidase inhibitor (DPP4i) compared to a sulfonylurea (SU) can delay the time to the subsequent treatment intensification (TI). Methods: Population-based administrative da...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberto, Giuseppe, Girardi, Anna, Barone-Adesi, Francesco, Pecere, Alessandro, Ientile, Valentina, Bartolini, Claudia, Da Cas, Roberto, Spila-Alegiani, Stefania, Ferrajolo, Carmen, Francesconi, Paolo, Trifirò, Gianluca, Poluzzi, Elisabetta, Baccetti, Fabio, Gini, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189773/
https://www.ncbi.nlm.nih.gov/pubmed/35707398
http://dx.doi.org/10.3389/fphar.2022.871052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189773/
https://www.ncbi.nlm.nih.gov/pubmed/35707398
http://dx.doi.org/10.3389/fphar.2022.871052

Ejemplares similares